Heaney A P, Harper R, Ennis C, Rooney D P, Sheridan B, Atkinson A B, Bell P M
Sir George E. Clark Metabolic Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
Clin Endocrinol (Oxf). 1997 Jun;46(6):735-43. doi: 10.1046/j.1365-2265.1997.2121024.x.
Although it is well established that hypercortisolism causes insulin resistance, the mechanisms responsible for impaired insulin action in Cushing's syndrome are unclear. This study investigated the contribution of the glucose/glucose-6-phosphate substrate cycle (G/G6P).
Eight patients with Cushing's syndrome and seven control subjects were studied. All had normal fasting plasma glucose.
Insulin action was assessed using the euglycaemic glucose clamp at insulin infusion rates of 0.4 and 2.0 mU/kg/min combined with a simultaneous infusion of [2(3)H]- and [6(3)-H]-glucose. Glucose/ glucose-6-phosphate cycle activity was calculated as the difference in glucose turnover rates determined separately for [2(3)H]- and [6(3)H]-glucose by selective enzymatic detritiation.
Exogenous glucose infusion rates required to maintain euglycaemia were significantly lower in Cushing's patients compared to controls, during the 0.4 mU/kg/min (7.8 +/- 1.2 vs 15.7 +/- 0.5 mumol/kg/min, P < 0.001) and the 2.0 mU/ kg/min insulin infusions (26.2 +/- 2.8 vs 51.5 +/- 3.5 mumol/ kg/min, P < 0.001). Endogenous glucose production was similar in both groups in the postabsorptive state (10.2 +/- 0.3 vs 10.8 +/- 0.4 mumol/kg/min, P = 0.50) and suppressed to a similar degree during hyperinsulinaemia. G/G6P cycle activity was markedly increased in the Cushing's group in the postabsorptive state (5.4 +/- 1.1 vs 2.0 +/- 0.5 mumol/kg/min, P = 0.028) and during the 0.4 mU/kg/min (3.2 +/- 0.6 vs 1.2 +/- 0.4 mumol/kg/min, P = 0.014) and 2.0 mU/kg/min insulin infusions (3.3 +/- 0.8 vs 1.1 +/- 0.5 mumol/kg/min, P = 0.049).
Patients with Cushing's syndrome show marked peripheral insulin resistance and enhanced hepatic G/G6P cycle activity. In the fasting state increased glucose/glucose-6-phosphate cycle activity may be a protective mechanism limiting hyperglycaemia. During hyperinsulinaemia G/G6P cycle activity was increased but insulin resistance was predominantly due to reduced peripheral glucose uptake.
虽然皮质醇增多症会导致胰岛素抵抗这一点已得到充分证实,但库欣综合征中胰岛素作用受损的机制尚不清楚。本研究调查了葡萄糖/葡萄糖-6-磷酸底物循环(G/G6P)的作用。
对8例库欣综合征患者和7例对照者进行了研究。所有患者空腹血糖均正常。
采用正常血糖葡萄糖钳夹技术,以0.4和2.0 mU/kg/min的胰岛素输注速率,并同时输注[2(3)H]-和[6(3)-H]-葡萄糖,评估胰岛素作用。通过选择性酶促去氚化分别测定[2(3)H]-和[6(3)H]-葡萄糖的葡萄糖周转率,计算葡萄糖/葡萄糖-6-磷酸循环活性。
在0.4 mU/kg/min(7.8±1.2 vs 15.7±0.5 μmol/kg/min,P<0.001)和2.0 mU/kg/min胰岛素输注期间(26.2±2.8 vs 51.5±3.5 μmol/kg/min,P<0.001),与对照组相比,库欣综合征患者维持正常血糖所需的外源性葡萄糖输注速率显著降低。两组在吸收后状态下内源性葡萄糖生成相似(10.2±0.3 vs 10.8±0.4 μmol/kg/min,P = 0.50),且在高胰岛素血症期间均被抑制到相似程度。在吸收后状态下,库欣综合征组的G/G6P循环活性显著增加(5.4±1.1 vs 2.0±0.5 μmol/kg/min,P = 0.028),在0.4 mU/kg/min(3.2±0.6 vs 1.2±0.4 μmol/kg/min,P = 0.014)和2.0 mU/kg/min胰岛素输注期间(3.3±0.8 vs 1.1±0.5 μmol/kg/min,P = 0.049)也是如此。
库欣综合征患者表现出明显的外周胰岛素抵抗和肝脏G/G6P循环活性增强。在空腹状态下,葡萄糖/葡萄糖-6-磷酸循环活性增加可能是限制高血糖的一种保护机制。在高胰岛素血症期间,G/G6P循环活性增加,但胰岛素抵抗主要是由于外周葡萄糖摄取减少。